Dodecanoic acid
|
Basic information |
| Metabolite name | Dodecanoic acid |
 | HMDB0000638 |
 |
C02679 |
 |
3893 |
| Synonyms | Lauric acid |
| No. of studies | 10 |
|
Basic information |
| Metabolite name | Dodecanoic acid |
| HMDB0000638 |
|
C02679 |
|
3893 |
| Synonyms | Lauric acid |
| No. of studies | 10 |
|
Relationship between Dodecanoic acid and depression (count: 10) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1024 | Type1 | CUMS group vs. control group | CA1 region of hippocampus | ICR mouse | Down |
| Study M1024 | Type1 | CUMS group vs. control group | DG region of hippocampus | ICR mouse | Down |
| Study M1024 | Type1 | CUMS group vs. control group | CA3 region of hippocampus | ICR mouse | Down |
| Study M1063 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M1111 | Type1 | CUMS group vs. control group | Plasma | C57BL/6 mouse | Down |
| Study M464 | Type1 | drug-naive MDD group vs. control group | Plasma | Human | Down |
| Study M464 | Type1 | drug-treatment MDD group vs. control group | Plasma | Human | Down |
| Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Up |
| Study M682 | Type1 | fenvalerate-treated male offspring group vs. control male offspring group | Thyroid | ICR mouse | Down |
| Study M682 | Type1 | fenvalerate-treated male offspring group vs. control male offspring group | Serum | ICR mouse | Down |
| Study M712 | Type1 | depression group vs. control group | Faece | Cynomolgus monkey | Up |
| Study M894 | Type1 | electromagnetic field exposure group vs. control group | Serum | C57BL/6J mouse | Up |
| Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M953 | Type2 | CRS + Shugan Granule group vs. CRS group | Faece | Sprague-Dawley rat | Down |